Meeder Asset Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,278
Closed -$30K 2015
2021
Q3
$30K Sell
6,278
-607
-9% -$3.49K ﹤0.01% 1279
2021
Q2
$45K Buy
6,885
+3,951
+135% +$27.6K ﹤0.01% 1166
2021
Q1
$21K Buy
+2,934
New +$24.8K ﹤0.01% 1392
2020
Q4
Sell
-4,824
Closed -$15K 2130
2020
Q3
$15K Sell
4,824
-4,002
-45% -$19K ﹤0.01% 1255
2020
Q2
$44K Buy
8,826
+8,366
+1,819% +$28.5K ﹤0.01% 953
2020
Q1
$2K Buy
460
+456
+11,400% +$1.97K ﹤0.01% 2109
2019
Q4
$0 Buy
+4
New +$23 ﹤0.01% 2369
2018
Q1
Sell
-315
Closed -$4K 1702
2017
Q4
$4K Buy
+315
New +$4.69K ﹤0.01% 1374
2017
Q2
Sell
-252
Closed -$5K 1818
2017
Q1
$5K Buy
+252
New +$5.63K ﹤0.01% 1083

Other funds holding PGEN

Meeder Asset Management's PGEN Position: Q4 2021 in Review

Meeder Asset Management sold out of Precigen (PGEN) in Q4 2021, closing a stake of 6,278 shares — an estimated $30K sold.

Meeder Asset Management first reported a position in PGEN in Q1 2017 and held it in 9 quarters. The position peaked at $45K in Q2 2021. 168 funds tracked by Wall St. Rank hold PGEN as of Q4 2021.

  • Meeder Asset Management reported no remaining Precigen position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 6,278 Precigen shares in Q4 2021, an estimated $30K.
  • Meeder Asset Management first reported a position in Precigen in Q1 2017 and held it in 9 quarters.
  • Meeder Asset Management's Precigen position peaked at $45K in Q2 2021.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.